Company Filing History:
Years Active: 2007-2014
Title: Frank Larsen: Innovator in Nucleic Acid Isolation and Sequencing
Introduction
Frank Larsen is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of molecular biology, particularly in the isolation and sequencing of nucleic acids. With a total of four patents to his name, Larsen's work has advanced the methodologies used in genetic research and diagnostics.
Latest Patents
Larsen's latest patents include innovative methods for isolating nucleic acids from samples. One of his inventions provides a method that involves contacting a sample with a detergent and a solid support, allowing soluble nucleic acid to bind to the support. This method can be coupled with further steps to isolate both DNA and RNA from the same sample. Another significant patent focuses on a method for determining a target nucleic acid sequence within a preparation that contains both target and non-target nucleic acid sequences. This method includes steps for hybridizing an oligonucleotide primer and incorporating labelled nucleotides, ultimately allowing for the sequencing of the target nucleic acid.
Career Highlights
Throughout his career, Frank Larsen has worked with prominent companies in the biotechnology sector, including Invitrogen Dynal AS and Life Technologies AS. His experience in these organizations has contributed to his expertise in nucleic acid technologies and has facilitated the development of his patented methods.
Collaborations
Larsen has collaborated with notable colleagues, including Arne Deggerdal and Arne Helge Deggerdal. These partnerships have likely enriched his research and innovation efforts in the field of molecular biology.
Conclusion
Frank Larsen's contributions to nucleic acid isolation and sequencing represent significant advancements in biotechnology. His patents reflect a commitment to improving methodologies that are essential for genetic research and diagnostics.